Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages
Forget Ozempic: There could be an even more effective weight-loss drug on the way
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
Eli Lilly’s weight-loss drug Zepbound might help cure your sleep apnea
Wegovy is no longer just a weight-loss drug
Could weight-loss drugs like Ozempic cause depression—or help treat it?
Why is Novo Nordisk’s stock up? Here’s what to know about its weight-loss drug Wegovy’s heart disease trials
Ozempic, other weight-loss drugs face backlash from companies, lawyers. What you need to know
Body Positivity Coverage Lags Way Behind Weight-Loss Stories
Pinterest Bans Weight-Loss Ads
Pinterest bans all weight-loss ads